Compare SUN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUN | QGEN |
|---|---|---|
| Founded | 1886 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 10.2B |
| IPO Year | N/A | 1996 |
| Metric | SUN | QGEN |
|---|---|---|
| Price | $52.64 | $45.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $63.75 | $50.07 |
| AVG Volume (30 Days) | 352.3K | ★ 1.1M |
| Earning Date | 02-10-2026 | 02-04-2026 |
| Dividend Yield | ★ 6.94% | 3.33% |
| EPS Growth | N/A | ★ 331.20 |
| EPS | ★ 2.93 | 1.84 |
| Revenue | ★ $21,870,000,000.00 | $2,070,781,000.00 |
| Revenue This Year | $2.83 | $7.07 |
| Revenue Next Year | $10.99 | $6.14 |
| P/E Ratio | ★ $18.07 | $24.67 |
| Revenue Growth | N/A | ★ 5.32 |
| 52 Week Low | $47.98 | $37.63 |
| 52 Week High | $59.88 | $51.88 |
| Indicator | SUN | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 45.64 |
| Support Level | $52.01 | $45.13 |
| Resistance Level | $52.98 | $46.17 |
| Average True Range (ATR) | 0.90 | 0.66 |
| MACD | -0.17 | -0.03 |
| Stochastic Oscillator | 28.17 | 39.50 |
Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).